Vadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug ...

Alembic Pharmaceuticals has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDAPantoprazole Sodium for Injection, 40 mg/vial ...

The injection is also prescribed for pathological hypersecretion conditions, including Zollinger-Ellison (ZE) Syndrome.

Alembic Pharmaceuticals (Alembic) announced that it has received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Pantoprazole Sodium.